Health
Can Moderna shares rally on higher vaccine efficacy against Delta variant? – ig.com
Covid-19 vaccine maker Moderna’s stock has been on a tear this year, hitting record highs.
- Moderna (Nasdaq: MRNA) share price falls to US$456.76 per share
- The US biotech said it will not exceed its 2021 vaccine production target
- Modernas jab may be more effective against the Delta variant than its rivals shot, a study suggested
- Feeling bullish or…
Continue Reading
-
Noosa News10 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
Noosa News24 hours agoPolice charge second man over alleged assault in Gold Coast car seller on Facebook’s Marketplace
-
General19 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply
-
Noosa News24 hours agoBIGSOUND Is Back For 2025 With Over 130 Emerging Artists